Skip to content
Home/ Early Warning: Cases and Ethical Guidance for Presymptomatic Testing in Genetic Diseases
Early Warning: Cases and Ethical Guidance for Presymptomatic Testing in Genetic Diseases

Early Warning: Cases and Ethical Guidance for Presymptomatic Testing in Genetic Diseases

by Smith, David H
No customer reviews yet ISBN 9780253334015

This book presents twenty-nine case studies that identify the most important ethical issues likely to emerge from new technologies of genetic testing and develops a series of guidelines based on the case studies. The authors believe that guideline formation is dependent on case analysis and that any statement of general guidelines must follow from concrete, practical discussion of specific situations. For these reasons, the guidelines presented are rooted in the case discussions and follow from the resolution of the cases. By providing the clinical origins and rationale behind each of its recommendations, the book aims to provide guidance for thinking through the ethical issues as well as a starting point for development of additional guidelines.

About the author

Product details

Pub dateNov 22, 1998
ISBN-100253334012
ISBN-139780253334015
LanguageEnglish
Last updated 2026-09-08 00:49
$40.67
In stock — ships in 24 hours with free tracking
Delivery by Monday, September 14, 2026
Qty
Sign in to Add to Saved list
Free delivery on orders over $35.
15-day returns. Any reason.
Secure checkout. We never store card details.

Readers who bought this also bought

More from Ethics
See all
Toward a More Natural Science
Kass, Leon R
$18.75
Case Files Medical Ethics and Professionalism
Toy, Eugene C
$56.26
Managing Relationships with Industry: A Physician's Compliance Manual
Schachter, Steven C
$58.00
Science and Ethics of Antipsychotic Use in Children
<p><i>The Science and Ethics of Antipsychotic Use in Children</i> reviews the latest findings for the safety and efficacy of the rapidly rising incidence of antipsychotic use in children and examines tensions that are created by off-label use, both in clinical psychiatric practice and research.<br>In the past ten years, the number of antipsychotics prescribed to children with psychiatric disorders has skyrocketed. Despite this rapid growth, most medications have been inadequately studied in children for safety or efficacy and many have serious adverse health. Measures are needed to ensure that the health and safety of children are being protected, and debates have emerged over whether or not clinical trials in this population should be conducted.</p>
$59.16
Addiction Neuroethics: The Ethics of Addiction Neuroscience Research and Treatment
<p>Research increasingly suggests that addiction has a genetic and neurobiological basis, but efforts to translate research into effective clinical treatments and social policy needs to be informed by careful ethical analyses of the personal and social implications. Scientists and policy makers alike must consider possible unintended negative consequences of neuroscience research so that the promise of reducing the burden and incidence of addiction can be fully realized and new advances translated into clinically meaningful and effective treatments. </p> <p>This volume brings together leading addiction researchers and practitioners with neuroethicists and social scientists to specifically discuss the ethical, philosophical, legal and social implications of neuroscience research of addiction, as well as its translation into effective, economical and appropriate policy and treatments. Chapters explore the history of ideas about addiction, the neuroscience of drug use and addiction, prevention and treatment of addiction, the moral implications of addiction neuroscience, legal issues and human rights, research ethics, and public policy.</p>
$121.58
Ethical Health Care
Illingworth, Patricia
$234.19